The FDA has accepted Alvotech (ALVO) and Teva's (TEVA) applications for AVT05, their proposed biosimilar to J&J's ...

Alvotech (ALVO) closed the last trading session at $11.80, gaining 0.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall ...

Alvotech (ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced that the FDA has ...

Key Insights Alvotech's significant private equity firms ownership suggests that the key decisions are influenced ...

Alvotech (ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced that the U.S. FDA has ...

ALVO Rapsodia 4-05 has been designed to support the patient during all surgical procedures and interventions: general surgery, vascular surgery, endoscopy, neurosurgery, gynecology, urology and ...

Is Alvotech (ALVO) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question. Alvotech is ...

The specialized operating table ALVO Serenada-C perfectly meets requirements needed for x-ray involved procedures. The floating table top performs smooth, fluent x-y movements to provide precise ...

Here is how Alvotech (ALVO) and Becton Dickinson (BDX) have performed compared to their sector so far this year.